FIGURE

Fig. 4

ID
ZDB-FIG-201026-20
Publication
Choi et al., 2020 - Prevention of mitochondrial impairment by inhibition of protein phosphatase 1 activity in amyotrophic lateral sclerosis
Other Figures
All Figure Page
Back to All Figure Page
Fig. 4

Effects of the blockade of PP1 on G93A and Q331-induced neurodegeneration.

a The representative image of mitochondria in the neurite of GFP+ primary cortical neuron with 40 nM I-2 treatment or shRNA lenti-viral infection after transfection of dsRed-mito and mALS genes, over 72 h. The mitochondrial image has been embossed using Photoshop and measured on the GFP+ cortical neuron. Scale bar, 5 μm. b Analysis of mitochondrial length in (a). GFP:CON = 1.00 ± 0.06 (n = 29 GFP+ neurons), GFP:shPP1α = 1.1 ± 0.09 (n = 17 GFP+ neurons) GFP:shPP1β=0.79 ± 0.87 (n = 7 GFP+ neurons), GFP:shPP1γ = 1.08 ± 0.05 (n = 27 GFP+ neurons), GFP:I-2 = 0.96 ± 0.05 (n = 30 GFP+ neurons), G93A:CON = 0.7 ± 0.02 (n = 30 GFP+ neurons), G93A:shPP1α = 1.00 ± 0.4 (n = 33 GFP+ neurons), G93A:shPP1β = 0.66 ± 0.02 (n = 30 GFP+ neurons), G93A:shPP1γ = 0.99 ± 0.05 (n = 20 GFP+ neurons), G93A:I-2 = 1.04 ± 0.06 (n = 30 GFP+ neurons), Q331K:CON = 0.65 ± 0.02 (n = 30 GFP+ neurons), Q331K:shPP1α = 1.1 ± 0.06 (n = 31 GFP+ neurons), Q331K:shPP1β = 0.74 ± 0.03 (n = 30 GFP+ neurons), Q331K:shPP1γ = 0.89 ± 0.6 (n = 19 GFP+ neurons), Q331K:I-2 = 0.98 ± 0.05 (n = 35 GFP+ neurons). Values are mean ± S.E.M. F(2,86) = 26.64, ****P < 0.0001 for CON groups; F(4,105) = 1.710, n.s.: not significant for GFP groups; F(4,138) = 20.02, ###P = 0.0001, ####P < 0.0001 for G93A groups; F(4,138) = 20.02, ##P = 0.0089, ####P < 0.0001 for Q331K groups by one-way ANOVA with Tukey’s post hoc analysis for multiple comparisons. c Quantification of cleaved caspase-3-positive neurons in GFP+ neurons with 40 nM I-2 treatment or shRNA lenti-viral infection following transfection of mALS genes, over 72 h. GFP:CON = 7.67 ± 2.06 (n = 6 independent primary culture), GFP:shPP1α = 35.61 ± 12.54 (n = 2 independent primary culture), GFP:shPP1β=8.28 ± 0.75 (n = 3 independent primary culture), GFP:shPP1γ = 17.11 ± 4.65 (n = 3 independent primary culture), GFP:I-2 = 7.5 ± 2.51 (n = 5 independent primary culture), G93A:CON = 26.59 ± 2.31 (n = 5 independent primary culture), G93A:shPP1α = 37.09 ± 5.51 (n = 2 independent primary culture), G93A:shPP1β = 18.39 ± 2.45 (n = 2 independent primary culture), G93A:shPP1γ = 12.09 ± 2.63 (n = 3 independent primary culture), G93A:I-2 = 13.79 ± 0.84 (n = 4 independent primary culture), Q331K:CON = 34.83 ± 1.370 (n = 3 independent primary culture), Q331K:shPP1α = 32.39 ± 2.39 (n = 2 independent primary culture), Q331K:shPP1β = 17.03 ± 6.39 (n = 3 independent primary culture), Q331K:shPP1γ=17.07 ± 1.44 (n = 3 independent primary culture), Q331K:I-2 = 12.57 ± 2.60 (n = 3 independent primary culture). Values are mean ± S.E.M. F(2,11) = 41.29, ****P < 0.0001 for CON groups; F(4,14) = 7.230, ***P = 0.0007 for GFP groups; F(4,11) = 14.03, ##P = 0.0096 for G93A:CON versus G93A: shPP1γ, ##P = 0.0073 for G93A:CON versus G93A: I-2; F(4,9) = 7.887, #P = 0.0327 for Q331K:CON versus Q331K: shPP1β, #P = 0.0327 for Q331K:CON versus Q331K: shPP1γ, ##P = 0.0089 by one-way ANOVA followed by Tukey’s multiple comparisons test. d Quantification of pyknotic cell in GFP+ neurons with 40 nM I-2 treatment or shRNA lenti-viral infection following transfection of mALS genes, over 72 h. GFP:CON = 9.39 ± 2.33 (n = 6 independent primary culture), GFP:shPP1α = 45.01 ± 14.25 (n = 2 independent primary culture), GFP:shPP1β = 11.08 ± 2.31 (n = 3 independent primary culture), GFP:shPP1γ = 15.40 ± 5.19 (n = 3 independent primary culture), GFP:I-2 = 6.64 ± 2.67 (n = 5 independent primary culture), G93A:CON = 34.85 ± 4.25 (n = 6 independent primary culture), G93A:shPP1α=41.18 ± 6.97 (n = 2 independent primary culture), G93A:shPP1β = 15.78 ± 0.16 (n = 2 independent primary culture), G93A:shPP1γ = 13.13 ± 4.84 (n = 3 independent primary culture), G93A:I-2 = 17.98 ± 3.12 (n = 5 independent primary culture), Q331K:CON = 42.76 ± 7.15 (n = 3 independent primary culture), Q331K:shPP1α = 38.71 ± 6.21 (n = 2 independent primary culture), Q331K:shPP1β = 21.69 ± 2.95 (n = 3 independent primary culture), Q331K:shPP1γ = 22.14 ± 1.44 (n = 3 independent primary culture), Q331K:I-2 = 14.45 ± 2.93 (n = 3 independent primary culture). Values are mean ± S.E.M. F(2,12) = 17.58, **P = 0.0012, ***P = 0.0007 for each CON group; F(4,14) = .101, ***P = 0.0007 for each GFP group; F(4,13) = 6.49, #P = 0.0245 for G93A:CON versus G93A:shPP1γ, #P = 0.0441 for G93A:CON versus G93A:I-2; F(4,9) = 7.405, #P = 0.0433 for Q331K:CON versus Q331K: shPP1β, #P = 0.0483 for Q331K:CON versus Q331K: shPP1γ, ##P = 0.0080 by one-way ANOVA followed by Tukey’s multiple comparisons test. e Analysis of total neurite length in (a). GFP:CON = 100 ± 8.70 (n = 57 GFP+ neurons), GFP:I-2 = 115.90 ± 9.90 (n = 22 GFP+ neuron), GFP: shPP1α=130.3 ± 18.51 (n = 9 GFP+ neuron), GFP:shPP1β=72.12 ± 8.25 (n = 16 GFP+ neuron), GFP:shPP1γ=60.66 ± 5.05 (n = 29 GFP+ neuron), G93A:CON = 61.61 ± 3.10 (n = 91 GFP+ neuron), G93A:I-2 = 106.3 ± 7.51 (n = 27 GFP+ neuron), G93A:shPP1α = 93.39 ± 13.05 (n = 21 GFP+ neuron), G93A:shPP1β = 57.56 ± 4.52 (n = 23 GFP+ neuron), G93A:shPP1γ = 88.06 ± 11.45 (n = 26 GFP+ neuron), Q331K:CON = 42.39 ± 3.47 (n = 25 GFP+ neuron), Q331K:I-2 = 122.2 ± 10.61 (n = 21 GFP+ neuron), Q331K:shPP1α=128.8 ± 17.3 (n = 23 GFP+ neuron), Q331K:shPP1β = 60.97 ± 6.15 (n = 27 GFP+ neuron), Q331K:shPP1γ = 94.81 ± 11.55 (n = 37 GFP+ neuron),. Values are mean ± S.E.M. F(2,170) = 19.98, ****P < 0.0001 for each CON group;F(4,128) = 7.415, #P = 0.0106, ##P = 0.0025 for GFP:I-2 versus GFP:shPP1γ, ##P = 0.0057 for GFP:shPP1α versus GFP:shPP1γ; F(4,183)=9.91, #P = 0.0235, #P = 0.0089, ###P = 0.0008 for each G93A group; F(4,128) = 10.63, ##P = 0.0044, ####P < 0.0001 for each Q331K group by one-way ANOVA followed by Tukey’s multiple comparisons test. f Analysis of total axonal length in (a). GFP:CON = 100 ± 10.33 (n = 56 GFP+ neuron), GFP:I-2 = 119.4 ± 11.51 (n = 22 GFP+ neuron), GFP: shPP1α = 141.4 ± 24.44 (n = 9 GFP+ neuron), GFP:shPP1β = 73.71 ± 9.06 (n = 16 GFP+ neuron), GFP:shPP1γ = 59.58 ± 6.13 (n = 29 GFP+ neuron), G93A:CON = 54.08 ± 3.02 (n = 86 GFP+ neuron), G93A:I-2 = 80.63 ± 4.57 (n = 27 GFP+ neuron), G93A:shPP1α = 02.8 ± 15.10 (n = 21 GFP+ neuron), G93A:shPP1β = 58.73 ± 6.10 (n = 23 GFP+ neuron), G93A:shPP1γ = 95.06 ± 13.3 (n = 26 GFP+ neuron), Q331K:CON = 49.70 ± 7.46 (n = 28 GFP+ neuron), Q331K:I-2 = 131.7 ± 15.21 (n = 21 GFP+ neuron), Q331K:shPP1α = 145.8 ± 20.67 (n = 23 GFP+ neuron), Q331K:shPP1β = 60.02 ± 7.01 (n = 27 GFP+ neuron), Q331K:shPP1γ = 98.4 ± 12.79 (n = 37 GFP+ neuron). Values are mean ± S.E.M. F(2, 167) = 15.91, ***P = 0.0001, ****P < 0.0001 for each CON group; F(4,127) = 5.083, #P = 0.0386 for each GFP group;F(4,178) = 9.565, #P = 0.0356, ###P = 0.0002, ####P < 0.0001 for each G93A group;F(4,131) = 4.236, #P = 0.0395, ###P = 0.0005, ####P < 0.0001 for each Q331K group by one-way ANOVA followed by Tukey’s multiple comparisons test.

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Cell Death Dis.